Long-term efficacy and safety of Oxcarbazepine (OXC) in clinical practice were evaluated on 160 epileptic patients, over a mean period of two years and eight months. Both patients received OXC in monotherapy and in add-on and showed either maintenance (75.65%) or an improvement (21.25%) in seizures control. Overall, Oxcarbazepine was well tolerated, with 9.03% of patients experiencing adverse events similar to those previously reported.
Titolo: | Efficacia a lungo termine del trattamento con Oxcarbazepina in monoterapia e in add-on: L'esperienza clinica nel Triveneto dopo un anno di follow-up |
Autori: | |
Data di pubblicazione: | 2004 |
Rivista: | |
Abstract: | Long-term efficacy and safety of Oxcarbazepine (OXC) in clinical practice were evaluated on 160 epileptic patients, over a mean period of two years and eight months. Both patients received OXC in monotherapy and in add-on and showed either maintenance (75.65%) or an improvement (21.25%) in seizures control. Overall, Oxcarbazepine was well tolerated, with 9.03% of patients experiencing adverse events similar to those previously reported. |
Handle: | http://hdl.handle.net/11390/1113959 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.